| Primary |
| Disseminated Intravascular Coagulation |
69.7% |
| Heparin-induced Thrombocytopenia |
10.9% |
| Thrombosis Prophylaxis |
3.5% |
| Thrombocytopenia |
3.0% |
| Anticoagulant Therapy |
2.0% |
| Thrombosis |
2.0% |
| Cardiovascular Disorder |
1.0% |
| Haemorrhagic Stroke |
1.0% |
| Meningism |
1.0% |
| Open Fracture |
1.0% |
| Dialysis |
0.5% |
| Hypokalaemia |
0.5% |
| Infertility |
0.5% |
| Iron Deficiency Anaemia |
0.5% |
| Pneumonia |
0.5% |
| Pulmonary Mycosis |
0.5% |
| Shock |
0.5% |
| Surgery |
0.5% |
| Thrombophlebitis |
0.5% |
| Venoocclusive Disease |
0.5% |
|
| White Blood Cell Count Increased |
10.7% |
| Sepsis |
9.9% |
| White Blood Cell Count Decreased |
8.3% |
| Thrombocytopenia |
7.4% |
| Haemorrhage |
6.6% |
| Renal Impairment |
6.6% |
| Prothrombin Time Prolonged |
5.8% |
| Septic Shock |
5.0% |
| Cerebral Haemorrhage |
4.1% |
| Heparin-induced Thrombocytopenia |
4.1% |
| Thrombosis |
4.1% |
| Infection |
3.3% |
| Pneumonia |
3.3% |
| Pulmonary Embolism |
3.3% |
| Renal Failure |
3.3% |
| Staphylococcal Infection |
3.3% |
| Upper Gastrointestinal Haemorrhage |
3.3% |
| Disseminated Intravascular Coagulation |
2.5% |
| Hypokalaemia |
2.5% |
| Platelet Count Decreased |
2.5% |
|
| Secondary |
| Acute Myeloid Leukaemia |
54.5% |
| Maternal Exposure During Pregnancy |
11.8% |
| Product Used For Unknown Indication |
7.3% |
| Thrombosis Prophylaxis |
7.3% |
| Prophylaxis |
6.4% |
| Acute Promyelocytic Leukaemia |
1.8% |
| Bone Marrow Conditioning Regimen |
1.8% |
| Candidiasis |
1.8% |
| Febrile Neutropenia |
1.8% |
| Post Transplant Lymphoproliferative Disorder |
1.8% |
| Atrial Fibrillation |
0.9% |
| Heparin-induced Thrombocytopenia |
0.9% |
| Pneumonia Klebsiella |
0.9% |
| Venous Thrombosis Limb |
0.9% |
|
| Heparin-induced Thrombocytopenia |
21.4% |
| Pyrexia |
14.3% |
| Stevens-johnson Syndrome |
14.3% |
| Gamma-glutamyltransferase Increased |
7.1% |
| Infarction |
7.1% |
| Leukocytosis |
7.1% |
| Motor Developmental Delay |
7.1% |
| Premature Baby |
7.1% |
| Subchorionic Haematoma |
7.1% |
| Thrombocytopenia |
7.1% |
|
| Concomitant |
| Prophylaxis |
17.9% |
| Acute Myeloid Leukaemia |
15.6% |
| Infection Prophylaxis |
10.2% |
| Product Used For Unknown Indication |
8.9% |
| Drug Use For Unknown Indication |
8.4% |
| Acute Promyelocytic Leukaemia |
5.2% |
| Prophylaxis Against Graft Versus Host Disease |
5.1% |
| Bone Marrow Conditioning Regimen |
4.7% |
| Acute Lymphocytic Leukaemia |
3.9% |
| Premedication |
2.9% |
| Aplastic Anaemia |
2.5% |
| Hypophagia |
2.5% |
| Antifungal Prophylaxis |
2.4% |
| Meningitis |
1.8% |
| Acute Graft Versus Host Disease |
1.6% |
| Infection |
1.6% |
| Antiviral Prophylaxis |
1.4% |
| Insomnia |
1.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.2% |
| Emergency Care |
1.1% |
|
| White Blood Cell Count Decreased |
23.6% |
| Weight Increased |
10.9% |
| Febrile Neutropenia |
9.1% |
| Leukopenia |
7.3% |
| Pyrexia |
5.5% |
| Somnolence |
5.5% |
| Thrombocytopenia |
5.5% |
| Graft Versus Host Disease |
3.6% |
| Leukocytosis |
3.6% |
| Rash Pustular |
3.6% |
| Sepsis |
3.6% |
| Stomatitis |
3.6% |
| Acute Myeloid Leukaemia |
1.8% |
| Blood Pressure Decreased |
1.8% |
| Bronchopulmonary Aspergillosis |
1.8% |
| Cytomegalovirus Test Positive |
1.8% |
| Enterocolitis Bacterial |
1.8% |
| Epstein-barr Virus Associated Lymphoproliferative Disorder |
1.8% |
| Hiccups |
1.8% |
| Interstitial Lung Disease |
1.8% |
|
